AlphaFold predicted structure
NDUFA5 · Q16718

Mean pLDDT
88.6/ 100
Confident
116 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)42%
- Low(50–70)3%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NADH:ubiquinone oxidoreductase subunit A5
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorder with complex I deficiency
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomaltype 2 diabetes mellitus
diabetes mellitus
neurodegenerative disease
Parkinson disease
multiple sclerosis
Alzheimer disease
lysosomal storage disease
polycystic ovary syndrome
gestational diabetes
Insulin resistance
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone
NDUFA5 · Q16718

Mean pLDDT
88.6/ 100
Confident
116 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0